Immupharma (IMM) RNS Announcements

Add to Alert list
Date Time Source Announcement
19 Apr 2024 07:00 AM
RNS
Grant of Share Options
02 Apr 2024 07:03 AM
RNS
New intellectual property strategy initiated
25 Mar 2024 07:25 AM
RNS
Incanthera provides Comm'l Update/Revenue F'casts
19 Mar 2024 07:00 AM
RNS
Grant of Share Options
14 Mar 2024 07:00 AM
RNS
IMMUPHARMA AT BIO-EUROPE SPRING 2024
06 Mar 2024 07:00 AM
RNS
Financial, Business and Portfolio Develop't Update
28 Dec 2023 01:35 PM
RNS
Holding(s) in Company
19 Dec 2023 02:50 PM
RNS
Holding(s) in Company
19 Dec 2023 07:00 AM
RNS
Simbec-Orion appointed as CRO
18 Dec 2023 07:15 AM
RNS
Incanthera - Comm'l Skincare Deal/£1M Fundraise
13 Sep 2023 03:47 PM
RNS
Holding(s) in Company
07 Sep 2023 07:00 AM
RNS
Result of Retail Offer and Director Shareholding
06 Sep 2023 01:53 PM
RNS
Holding(s) in Company
31 Aug 2023 07:02 AM
RNS
WRAP Retail Offer for up to £0.5m
31 Aug 2023 07:01 AM
RNS
Subscription to raise £1.35m; Sharing Agr, RPT
31 Aug 2023 07:00 AM
RNS
Interim results
21 Aug 2023 07:00 AM
RNS
Extension of warrants in Incanthera plc
11 Aug 2023 12:04 PM
RNS
Directorate Change
30 Jun 2023 01:12 PM
RNS
Result of AGM
19 Jun 2023 07:00 AM
RNS
Lupuzor Update
06 Jun 2023 07:00 AM
RNS
IMM RNS Posting of RA and Notice of AGM 30 June 23
18 May 2023 07:00 AM
RNS
Positive Pre-IND meeting with FDA
11 May 2023 07:00 AM
RNS
Final Results
10 May 2023 01:56 PM
RNS
Holding(s) in Company
19 Apr 2023 07:00 AM
RNS
Lupozor Update - FDA confirms Type-C meeting date
12 Apr 2023 07:00 AM
RNS
CIDP P140 Clinical Program Update
27 Mar 2023 07:00 AM
RNS
LupuzorT Update
09 Mar 2023 04:35 PM
RNS
Price Monitoring Extension
06 Mar 2023 07:00 AM
RNS
Collaboration with Orano on ImmuPharma Peptide
06 Feb 2023 07:00 AM
RNS
LupuzorT Update
27 Jan 2023 04:25 PM
RNS
TR-1: Notification of major holdings
04 Jan 2023 05:26 PM
RNS
TR-1: Notification of major holdings
04 Jan 2023 04:40 PM
RNS
Second Price Monitoring Extn
04 Jan 2023 04:35 PM
RNS
Price Monitoring Extension
03 Jan 2023 04:58 PM
RNS
TR-1: Notification of major holdings
22 Dec 2022 07:55 AM
RNS
Grant of Options
22 Dec 2022 07:00 AM
RNS
End of Year Update
22 Nov 2022 03:15 PM
RNS
Holding(s) in Company
14 Nov 2022 04:40 PM
RNS
Second Price Monitoring Extn
14 Nov 2022 04:35 PM
RNS
Price Monitoring Extension
11 Nov 2022 07:31 AM
RNS
Lupuzor Update
11 Oct 2022 04:40 PM
RNS
Second Price Monitoring Extn
11 Oct 2022 04:35 PM
RNS
Price Monitoring Extension
07 Oct 2022 04:44 PM
RNS
Company Secretary Change
30 Sep 2022 07:30 AM
RNS
Lupuzor Update
30 Sep 2022 07:00 AM
RNS
Interim Results or the 6mths Ended 30 June 2022
29 Sep 2022 04:40 PM
RNS
Second Price Monitoring Extn
29 Sep 2022 04:37 PM
RNS
Price Monitoring Extension
14 Sep 2022 10:04 AM
RNS
Written Response received from the FDA
07 Sep 2022 08:25 AM
RNS
Exercise of Options
UK 100